2,302
Views
6
CrossRef citations to date
0
Altmetric
HPV – Research Paper

Key stakeholder perspectives on challenges and opportunities for rural HPV vaccination in North and South Carolina

, ORCID Icon, , , , & ORCID Icon show all
Article: 2058264 | Received 22 Dec 2021, Accepted 16 Mar 2022, Published online: 19 Apr 2022

References

  • Centers for Disease Control and Prevention. Cancers associated with Human Papillomavirus, United States - 2014-2018 [Internet]. Atlanta, GA; 2021. https://www.cdc.gov/cancer/uscs/about/data-briefs/no26-hpv-assoc-cancers-UnitedStates-2014-2018.htm .
  • Centers for Disease Control and Prevention. TeenVaxView. 2019 Adolescent HPV vaccination coverage dashboard. CDC [Internet]. TeenVaxView; 2021. https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/index.html .
  • U.S. Department of Health and Human Services. Healthy people 2030 - IID‑08 —Increase the proportion of adolescents who get recommended doses of the HPV vaccine. 2020
  • Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, Fredua B, McNamara L, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 Years — United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(33):1109–8. doi:10.15585/mmwr.mm6933a1.
  • Lake PW, Kasting ML, Christy SM, Vadaparampil ST. Provider perspectives on multilevel barriers to HPV vaccination. Hum Vaccines Immunother. 2019;15(7–8):1784–93. doi:10.1080/21645515.2019.1581554.
  • Vielot NA, Butler AM, Brookhart MA, Becker-Dreps S, Smith JS. Patterns of use of Human Papillomavirus and other adolescent vaccines in the United States. J Adolesc Health. 2017;61(3):281–87. doi:10.1016/j.jadohealth.2017.05.016.
  • Fazekas KI, Brewer NT, Smith JS. HPV vaccine acceptability in a rural Southern area. J Women’s Health. 2008;17(4):539–48. doi:10.1089/jwh.2007.0489.
  • Boyd ED, Phillips JM, Schoenberger YMM, Simpson T. Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine. 2018;36:4126–33. doi:10.1016/j.vaccine.2018.04.085.
  • Rodriguez SA, Mullen PD, Lopez DM, Savas LS, Fernández ME. Factors associated with adolescent HPV vaccination in the U.S.: a systematic review of reviews and multilevel framework to inform intervention development. Prev Med (Baltim). 2020;131:105968. doi:10.1016/j.ypmed.2019.105968.
  • Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to Human Papillomavirus vaccination among US Adolescents a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82. doi:10.1001/jamapediatrics.2013.2752.
  • Vanderpool RC, Stradtman LR, Brandt HM. Policy opportunities to increase HPV vaccination in rural communities. Hum Vaccines Immunother. 2019;15(7–8):1527–32. doi:10.1080/21645515.2018.1553475.
  • Zahnd WE, Harrison SE, Stephens HC, Messersmith AR, Brandt HM, Hastings TJ, Eberth JM. Expanding access to HPV vaccination in South Carolina through community pharmacies: a geospatial analysis. J Am Pharm Assoc. 2020;60(6):e153–7. doi:10.1016/j.japh.2020.05.005.
  • Monnat SM, Rhubart DC, Wallington SF. Differences in Human Papillomavirus vaccination among adolescent girls in metropolitan versus non-metropolitan areas: considering the moderating roles of maternal socioeconomic status and health care access. Matern Child Health J. 2016;20(2):315–25. doi:10.1007/s10995-015-1831-x.
  • Sundstrom B, Cartmell KB, White AA, Well H, Pierce JY, Brandt HM. Correcting HPV vaccination misinformation online: evaluating the HPV vaccination NOW social media campaign. Vaccines. 2021;9(4):352. doi:https://doi.org/10.3390/vaccines9040352 .
  • Grzywacz JG, Fuqua J. The social ecology of health: leverage points and linkages. Behav Med. 2000;26(3):101–15. doi:10.1080/08964280009595758.
  • Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care [Internet]. 2007;19:349–57. https://academic.oup.com/intqhc/article/19/6/349/1791966 .
  • Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82. doi:10.1177/1525822X05279903.
  • Koenig CJ, Abraham T, Zamora KA, Hill C, Kelly PA, Uddo M, Hamilton M, Pyne JM, Seal KH. Pre-Implementation strategies to adapt and implement a veteran peer coaching intervention to improve mental health treatment engagement among rural veterans. J Rural Health. 2016;32(4):418–28. doi:10.1111/jrh.12201.
  • Hamilton AB, Finley EP, Koenig CJ, Abraham T, Zamora KA, Hill C, Kelly PA, Uddo M, Hamilton M, Pyne JM, et al. Qualitative methods in implementation research: an introduction. Psychiatry Res. 2019;32:279–89.
  • Skillman M, Cross-Barnet C, Friedman Singer R, Rotondo C, Ruiz S, Moiduddin A. A framework for rigorous qualitative research as a component of mixed method rapid-cycle evaluation. Qual Health Res. 2019;29(2):279–89. doi:10.1177/1049732318795675.
  • Averill JB. Matrix analysis as a complementary analytic strategy in qualitative inquiry. Qual Health Res. 2002;12(6):855–66. doi:10.1177/104973230201200611.
  • Nichols SB. Vaccines for children program. J Ark Med Soc [Internet]. 1994;91:119–20. https://www.cdc.gov/vaccines/programs/vfc/index.html .
  • Murthy V Confronting health misinformation. 2021.
  • Murthy BP, Zell E, Kirtland K, Jones-Jack N, Harris LT, Sprague C, Schultz J, Le Q, Bramer CA, Kuramoto S, et al. Impact of the COVID-19 pandemic on administration of selected routine childhood and adolescent vaccinations — 10 U.S. Jurisdictions, March-September 2020. MMWR Recomm Rep. 2021;70:840–45.
  • Green LA, Potworowski G, Day A, May-Gentile R, Vibbert D, Maki B, Kiesel L. Sustaining “meaningful use” of health information technology in low-resource practices. Ann Fam Med. 2015;13(1):17–22. doi:10.1370/afm.1740.
  • Greenberg AJ, Haney D, Blake KD, Moser RP, Hesse BW. Differences in access to and use of electronic personal health information between rural and urban residents in the United States. J Rural Health. 2018;34:s30–8. doi:10.1111/jrh.12228.
  • Thompson EL, Daley EM, Washburn T, Salisbury-Keith K, Saslow D, Fontenot HB, Zimet GD. School-Entry requirements for HPV vaccination: part of the patchwork for HPV-related cancer prevention. Hum Vaccines Immunother [Internet]. 2021;17(7):1975–79. doi:https://doi.org/10.1080/21645515.2020.1851130 .
  • Thompson EL, Livingston MD, Daley EM, Saslow D, Zimet GD. Rhode Island Human Papillomavirus vaccine school entry requirement using provider-verified report. Am J Prev Med. 2020;59(2):274–77. doi:10.1016/j.amepre.2020.02.022.
  • Hansen CE, Okoloko E, Ogunbajo A, North A, Niccolai LM. Acceptability of school-based health centers for Human Papillomavirus vaccination visits: a mixed-methods study. J Sch Health. 2017;87(9):705–14. doi:10.1111/josh.12540.
  • Bozigar M, Faith TD, White AA, Drayton KD, Fabick A, Cartmell KB. A cross-sectional survey to evaluate potential for partnering with school nurses to promote human papillomavirus vaccination. Prev Chronic Dis. 2020;17:1–10. doi:10.5888/pcd17.190451.